H. Ahmed et al., “Comparative Outcomes of Glucagon-Like Peptide-1 Receptor Agonists versus Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Cirrhosis”, ASIDE GI, vol. 2, no. 4, pp. 1–7, Jul. 2026, doi: 10.71079/ASIDE.GI.072726751.